According to Galectin Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -S$39.86 Million, an increase over its 2024 earnings that were of -S$60.81 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.